HUMANIN TRIFLUOROACETATE(330936-69-1)
- Name: HUMANIN TRIFLUOROACETATE
- Synonyms:1-24-Proteinhumanin (human); 188: PN: US20090053203 SEQID: 188 claimed protein; 1: PN: JP2006213632SEQID: 1 claimed protein; 1: PN: US20060100253 SEQID: 1 unclaimed sequence; 1:PN: WO2009040017 PAGE: 98 claimed protein; 2: PN: WO03045988 SEQID: 2 claimedsequence; 2: PN: WO2009117596 SEQID: 1 unclaimed sequence; 317: PN:WO2005051988 SEQID: 317 claimed protein; 369: PN: WO0176532 SEQID: 91 claimedprotein; 3: PN: WO03106683 SEQID: 3 claimed sequence; 40: PN: WO2004047728SEQID: 7249 claimed sequence; 48: PN: WO0181361 SEQID: 47 claimed protein; 4:PN: WO2006019365 SEQID: 4 claimed sequence; 4: PN: WO2008115525 SEQID: 188claimed protein; 5: PN: WO0121787 SEQID: 5 claimed sequence; 60: PN:WO2008058016 SEQID: 60 claimed protein; 7: PN: WO0121786 SEQID: 5 claimedsequence; 7: PN: WO2009135165 SEQID: 14 unclaimed sequence; Humanin; Humanin(human clone CG202524-01); Protein (human clone 1 humanin sequence homolog);Protein Humanin (human); T lymphocyte activation-associated protein PRO86272(human)
- Molecular Formula:C119H204 N34 O32 S2
- Molecular Weight:2801.26
- CAS Registry Number:330936-69-1
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 20667-19-0/METHYLTRIPHENYLPHOSPHONIUM IODIDE
- 98330-00-8/2-[8-({8-[(diaminomethylidene)amino]-5-methyl-4-oxooctyl}amino)octyl]guanidine
- 51639-48-6/4'-PIPERAZINOACETOPHENONE
- 89354-45-0/Riligustilide
- 37831-90-6/tetracyclo[6.1.0.0~2,4~.0~5,7~]nonane
- 17609-31-3/2,4,6-Octatrienal
- 688-23-3/1-butyl-1-(2-cyanoethyl)urea
- 73728-48-0/2-[(3-bromobenzyl)(pyridin-2-yl)amino]-N-ethyl-N-methylethanaminium (2Z)-3-carboxyprop-2-enoate
- 41762-76-9/3-Chlorocarbonyl-1-methanesulfonyl-2-imidazolidinone
- 34693-48-6/3-(2-chloroethyl)-1-[6-(2-chloroethylcarbamoyl-nitroso-amino)hexyl]-1-nitroso-urea
- 68953-59-3/Ethanaminium, 2-amino-N-(2-aminoethyl)-N-(2-hydroxyethyl)-N-methyl-, N,N-bis(hydrogenated tallow acyl) derivs, Me sulfates (salts)
- 207459-38-9/â-D-Glucopyranoside,(1aR,1bS,2S,5aR,6S,6aR)- 6-[(6-deoxy-R-L-mannopyranosyl)oxy]-1a,1b,- 2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]- pyran-2-yl
- 115559-71-2/Sulfurous acid, monosodium salt, reaction products with m-cresol-formaldehyde-nonylphenol polymer
- 91295-35-1/MSH, N(alpha)-Bct-1-Ser-4-Nle-7-Phe-alpha-
- 163089-74-5/5H-Cyclopenta[2,1-b:3,4-b']dipyridine,5-[(1-oxido-4-pyridinyl)methyl]-5-(4-pyridinylmethyl)- (9CI)
- 18600-02-7/ethyl 2,4,4,7-tetramethyl-5,6,7,8-tetrahydro-4H-chromene-3-carboxylate
- 51127-28-7/DL-5-BENZOYLAMINO-5-BENZYL-4-OXO-1,3-DIOXANE
- 141563-84-0/1,2-DICHLORO-1,1,3,3,3-PENTAFLUOROPROPANE
- 80832-89-9/4'-hydroxymethohexital
- 330936-69-1/HUMANIN TRIFLUOROACETATE
- 10192-92-4/4,4'-[(Dibutylstannylene)bis(oxy)]bis[(Z)-4-oxo-2-butenoic acid]
- 109985-87-7/19-Norlanosta-5,24-dien-11-one,3,26-dihydroxy-9-methyl-, (3b,9b,10a,24E)-
- 76204-66-5/[4-(4-propanoylphenyl)diazenylphenyl] hexanoate
- 15205-19-3/1-(2,6-dichlorophenyl)-N-methylmethanamine
- 65990-96-7/2-benzyl-3-methyl-1-oxoquinoxalin-1-ium-4(1H)-olate
- 829-89-0/2-[(diethoxyphosphanyl)oxy]-1,3,2-dioxaphospholane
- 108742-10-5/(1S,2S,3R,5R)-3-(2,6-diamino-9H-purin-9-yl)-5-(hydroxymethyl)cyclopentane-1,2-diol
- 2846-90-4/[1,3]thiazolo[5,4-d]pyriMidin-7-aMin
- 33472-72-9/o-Methylcarbanilic acid 1-methyl-3-pyrrolidinyl ester
- 54288-70-9/4-Bromopiperidine hydrobromide